In the STEP-HFpEF and STEP-HFpEF-DM trials, semaglutide also significantly improved symptoms, physical function, and NT-proBNP levels in patients with HFpEF, thereby expanding the therapeutic potential of GLP-1 RAs beyond atherosclerotic CVD [35,36]
On the contrary, oral administration of BCAA granules to patients with advanced cirrhosis resulted in a significant increase in IFN- levels, which alleviated the deterioration of the disease caused by impaired DCs function, providing evidence for nutritional therapy with amino acids (108)
Its allure stems from its ability to help people lose significant amounts of weight
To this end, it has been hypothesized that eliminating all xenobiotic secondary metabolites and plant antigens may provide more benefits than those offered by standard low-carbohydrate or ketogenic diets
These findings are consistent with data accessed on April 24, 2025